메뉴 건너뛰기




Volumn 146, Issue 3, 2014, Pages 529-530

The growing challenge of nontuberculous mycobacteria

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; MACROLIDE; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; STEROID;

EID: 84907208452     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0279     Document Type: Editorial
Times cited : (5)

References (10)
  • 1
    • 41349106396 scopus 로고    scopus 로고
    • Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City
    • Bodle EE, Cunningham JA, Della-Latta P, Schluger NW, Saiman L. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis. 2008; 14 (3): 390-396.
    • (2008) Emerg Infect Dis , vol.14 , Issue.3 , pp. 390-396
    • Bodle, E.E.1    Cunningham, J.A.2    Della-Latta, P.3    Schluger, N.W.4    Saiman, L.5
  • 2
    • 84874397054 scopus 로고    scopus 로고
    • Update on the epidemiology of pulmonary nontuberculous mycobacterial infections
    • Kendall BA, Winthrop KL. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013; 34 (1): 87-94.
    • (2013) Semin Respir Crit Care Med , vol.34 , Issue.1 , pp. 87-94
    • Kendall, B.A.1    Winthrop, K.L.2
  • 4
    • 0035846326 scopus 로고    scopus 로고
    • Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent
    • Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001; 345 (15): 1098-1104.
    • (2001) N Engl J Med , vol.345 , Issue.15 , pp. 1098-1104
    • Keane, J.1    Gershon, S.2    Wise, R.P.3
  • 5
    • 84907201015 scopus 로고    scopus 로고
    • Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada
    • Brode SK, Jamieson FB, Ng R, et al. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. Chest. 2014; 146 (3): 563-572.
    • (2014) Chest , vol.146 , Issue.3 , pp. 563-572
    • Brode, S.K.1    Jamieson, F.B.2    Ng, R.3
  • 6
    • 84863356932 scopus 로고    scopus 로고
    • Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease
    • Huang CT, Tsai YJ, Wu HD, et al. Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2012; 16 (4): 539-545.
    • (2012) Int J Tuberc Lung Dis , vol.16 , Issue.4 , pp. 539-545
    • Huang, C.T.1    Tsai, Y.J.2    Wu, H.D.3
  • 7
    • 84874397842 scopus 로고    scopus 로고
    • Underlying host risk factors for nontuberculous mycobacterial lung disease
    • Chan ED, Iseman MD. Underlying host risk factors for nontuberculous mycobacterial lung disease. Semin Respir Crit Care Med. 2013; 34 (1): 110-123.
    • (2013) Semin Respir Crit Care Med , vol.34 , Issue.1 , pp. 110-123
    • Chan, E.D.1    Iseman, M.D.2
  • 8
    • 84874283485 scopus 로고    scopus 로고
    • Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011
    • de Mello KG, Mello FC, Borga L, et al. Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011. Emerg Infect Dis. 2013; 19 (3): 393-399.
    • (2013) Emerg Infect Dis , vol.19 , Issue.3 , pp. 393-399
    • De Mello, K.G.1    Mello, F.C.2    Borga, L.3
  • 9
    • 84902109958 scopus 로고    scopus 로고
    • Macrolide/azalide therapy for nodular/bronchiectatic: Mycobacterium avium complex lung disease
    • Wallace RJ Jr, Brown-Elliott BA, McNulty S, et al. Macrolide/azalide therapy for nodular/bronchiectatic: Mycobacterium avium complex lung disease. Chest. 2014; 146 (2): 276-282.
    • (2014) Chest , vol.146 , Issue.2 , pp. 276-282
    • Wallace, R.J.1    Brown-Elliott, B.A.2    McNulty, S.3
  • 10
    • 33744908339 scopus 로고    scopus 로고
    • Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease
    • Lam PK, Griffi th DE, Aksamit TR, et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2006; 173 (11): 1283-1289.
    • (2006) Am J Respir Crit Care Med , vol.173 , Issue.11 , pp. 1283-1289
    • Lam, P.K.1    Griffi Th, D.E.2    Aksamit, T.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.